Results 231 to 240 of about 1,462,796 (292)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Minimal Input, Maximum Insight: Inferring Material Parameters From Solar Cell JV Curves Alone. [PDF]

open access: yesSmall Methods
Williams C   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy